Labiotech.eu

Interview 15 Mar 2021

Developing a Vaccine that Protects Against Covid-19 Variants

Despite the promise of several approved Covid-19 vaccines and the widespread rollout of vaccination programs around the world, recent mutations in the virus causing Covid-19 are raising concern. Can the current vaccines protect against different coronavirus variants? Paul Higham became CEO of the Finnish firm Valo Therapeutics in 2020. The company was founded in 2016 […]

March 15, 2021 - 8 minutesmins - By Larissa Warneck-Silvestrin

Antoine Papiernik Sofinnova Partners Biotech Entrepreneurs

Opinion 8 Mar 2021

Advice for my Younger Self: How to Be a VC in Life Sciences

Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners, looks back at where he was two decades ago and shares what he would tell his younger self about being a life sciences VC. I am not a scientist or a doctor. Twenty years ago, when I was starting my career in this business, someone like […]

March 8, 2021 - 5 minutesmins - By Antoine Papiernik

News and Trends 4 Mar 2021

Galapagos and Gilead Soldier On After Inflammatory Disease Flops

Clinical and regulatory setbacks have left the star biotech duo Gilead and Galapagos smarting and their stock value bruised in recent months. Yet the pair claim to be well capitalized to weather the storm and determined to do so together. The two companies forged an unusual blockbuster agreement in 2019, valued at around €4.5B ($5.1B), […]

March 4, 2021 - 4 minutesmins - By Victor Kotsev

Interview 3 Mar 2021

The Promises of CRISPR Genome Editing in Biomedicine

Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the advantages of CRISPR gene editing over other technologies and what the future holds for the genome editing field. For decades, gene editing required engineering DNA-cutting enzymes, such as zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), for every specific […]

March 3, 2021 - 5 minutesmins - By Larissa Warneck-Silvestrin

How is Bioprocessing 4.0 Revolutionizing Biomanufacturing?

The digital transformation of biopharmaceutical process development is known as Bioprocessing 4.0. Using the internet of things, digital biomanufacturing creates a network of data sources, materials, equipment, and industry representatives. This creates a competitive advantage, increases productivity, and boosts the value of biomanufacturing. We have spoken to Merrilee Whitney, Head of the BioContinuum™ platform at Merck* […]

March 2, 2021 - 6 minutesmins - By External Contributor

In Depth 1 Mar 2021

How Are European Biotechs Tackling the Cardiovascular Disease Problem?

Cardiovascular diseases may not regularly grab the headlines, but they’re the leading cause of mortality globally, making up over 30% of all deaths worldwide. While there are many established treatments on the market, there’s still a need for more effective treatments – can biotech companies provide the answer? We all know that frequent exercise, a […]

March 1, 2021 - 9 minutesmins - By Farhan Mitha

News and Trends 25 Feb 2021

Legal Fights Accompany Big Fundraises in Liquid Biopsy Scene

A recent patent fight between the liquid biopsy companies Natera and Inivata is only the latest of many spats over DNA sequencing technology that could potentially revolutionize the detection and treatment of cancer. Earlier this month, the UK-US biotech Inivata raised €29M in the second closing of a Series C round. The company will use […]

February 25, 2021 - 5 minutesmins - By Anita Chakraverty

Investment Gap finance savings currency train bridge

News and Trends 23 Feb 2021

European Cancer Deals Increasingly Focus on Natural Killer Cells

Natural killer cells are becoming a hot topic in the booming cancer cell therapy scene, with the field’s latest big deal being a €640M licensing agreement between the French biotech Cellectis and US company Cytovia. T-cell immunotherapies like CAR T-cell therapy have revolutionized cancer treatment in recent times. However, they have a significant disadvantage. The […]

February 23, 2021 - 6 minutesmins - By Kostas Vavitsas

Interview 22 Feb 2021

How Automation Can Augment Drug Discovery Research

Robotics and artificial intelligence are rapidly changing the way we discover drugs. Martin-Immanuel Bittner, CEO and co-founder of Arctoris, discusses the benefits and challenges of introducing automation in drug discovery efforts. The Oxford-based startup Arctoris was established in 2016 with the objective of offering remote access to automated drug discovery. At a time when researchers […]

February 22, 2021 - 8 minutesmins - By External Contributor

Industrial plant sustainability bioeconomy

News and Trends 18 Feb 2021

Cannabinoids in Focus after GW Pharmaceuticals Snapped up for €6B

This month’s €6B acquisition of the UK heavyweight GW Pharmaceuticals by Jazz Pharmaceuticals has been hailed as a major validation of the medical cannabinoid industry. The deal is the largest to date in the medical cannabinoid field. Jazz’s offer valued GW’s shares nearly 50% higher than their previous day’s close. The acquisition is expected to […]

February 18, 2021 - 6 minutesmins - By Victor Kotsev

News and Trends 16 Feb 2021

Cancer Research UK Cuts Two Biotech Collaborations Amid Pandemic Squeeze

The major research funder CRUK and two of the biotech companies it works with have decided to cut development ties as the financial impact of the coronavirus disease pandemic continues to bite. Cancer Research UK (CRUK) is a prolific research charity, running a multitude of collaborations with academics and biotech companies around the world. However, […]

February 16, 2021 - 4 minutesmins - By Anita Chakraverty

Best in Biotech 10 Feb 2021

Top Neurotech Startups Unlocking the Brain in Russia

Russia has established itself as a hub for neurotech startups, attracting scientists and business people keen to understand, treat, and repair the human brain. Here are the startups leading the charge of neurotech innovation in Russia. Neurotechnology is a field of research that aims to read and influence the brain. Turns out that neurotech is […]

February 10, 2021 - 6 minutesmins - By Carlos de Rojas

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Developing a Vaccine that Protects Against Covid-19 Variants

Advice for my Younger Self: How to Be a VC in Life Sciences

Galapagos and Gilead Soldier On After Inflammatory Disease Flops

The Promises of CRISPR Genome Editing in Biomedicine

How is Bioprocessing 4.0 Revolutionizing Biomanufacturing?

How Are European Biotechs Tackling the Cardiovascular Disease Problem?

Legal Fights Accompany Big Fundraises in Liquid Biopsy Scene

European Cancer Deals Increasingly Focus on Natural Killer Cells

How Automation Can Augment Drug Discovery Research

Cannabinoids in Focus after GW Pharmaceuticals Snapped up for €6B

Cancer Research UK Cuts Two Biotech Collaborations Amid Pandemic Squeeze

Top Neurotech Startups Unlocking the Brain in Russia

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!